| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9008207 | International Immunopharmacology | 2005 | 7 Pages |
Abstract
Conversion from cyclosporine to tacrolimus is recommended for patients with a kidney transplant, in which there has been a progressive fall in renal function. It leads to stabilisation or even improvement of transplant function and a reduction in cardiovascular risk factors.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Helge Hohage, U. Welling, M. Heck, M. Zeh, U. Gerhardt, B.M. Suwelack,